Nuvation Bio NUVB Total debt

Total debt at other companies

Bristol-Myers SquibbBMY

$43.33B-12.3%

PfizerPFE

$64.43B+4.9%

Rigel PharmaceuticalsRIGL

$68.36M+5,079%

ImmunomeIMNM

$3.69M-22.6%

Inhibrx Biosciences, Inc.INBX

$180.9M+69.8%

ArriVent BioPharma, Inc.AVBP

$419K+204%

FAQ

What is Nuvation Bio's total debt?

Nuvation Bio (NUVB) reported total debt of $9.52M in Q2 2026.

How has Nuvation Bio's total debt changed year-over-year?

Nuvation Bio's total debt decreased by 83.5% year-over-year, from $57.76M to $9.52M.

What is the long-term trend for Nuvation Bio's total debt?

Over 5 years (2020 to 2025), Nuvation Bio's total debt has grown at a 69.5% compound annual growth rate (CAGR), from $4.1M to $57.36M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.